Transformation of Cilostazole Nanosuspension into Nanocrystal to Increase the Product Stability and Dissolution Rate

Authors

  • Isameddin Aghrbi Department of Pharmaceutics, Semmelweis University, Hőgyes Endre Street 7, Budapest, H-1092 Hungary
  • Viktor Fülöp Department of Pharmaceutics, Semmelweis University, Hőgyes Endre Street 7, Budapest, H-1092 Hungary
  • Géza Jakab Department of Pharmaceutics, Semmelweis University, Hőgyes Endre Street 7, Budapest, H-1092 Hungary
  • Nikolett Kállai-Szabó Department of Pharmaceutics, Semmelweis University, Hőgyes Endre Street 7, Budapest, H-1092 Hungary
  • Emese Balogh Department of Pharmaceutics, Semmelweis University, Hőgyes Endre Street 7, Budapest, H-1092 Hungary
  • István Antal Department of Pharmaceutics, Semmelweis University, Hőgyes Endre Street 7, Budapest, H-1092 Hungary

DOI:

https://doi.org/10.33892/aph.2021.91.165-166

Keywords:

Cilostazol, wet milling, nanosuspension, solidification, extrusion/spheronization, PXRD

Published

2021-11-15

How to Cite

(1)
Aghrbi, I.; Fülöp, V.; Jakab, G.; Kállai-Szabó, N.; Balogh, E.; Antal, I. Transformation of Cilostazole Nanosuspension into Nanocrystal to Increase the Product Stability and Dissolution Rate. Acta Pharm Hung 2021, 91, 165-166.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License